ArticleFrontiers in oncology2023

Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience.

Paolo Borghetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.